NOSAI NOSAI
|
|
- つかさ くぬぎ
- 5 years ago
- Views:
Transcription
1 NOSAI NOSAI NOSAI NOSAI NOSAI NOSAI NOSAI NOSAI NOSAI NOSAI
2 NOSAI NOSAI
3 NOSAI NOSAI NOSAI FSFS FS FS FS Salmonella Typhimurium ST Salmonella Dublin SD SD ST ST
4 NOSAI S. Aberdeen TMR χ S. Aberdeen O11 i S.Aberdeen PP Salmonella P S. Aberdeen O4 SalmonellaO4 S Salmonella TyphimuriumST Salmonella sp. O4 ioi O4 i ST O4 S O S O4 SST O4 i O4 i ST PCR Xba PFGE multiple-locus variable number tandem repeat analysismlva O4 i ST H2 fljab-hin PFGE MLVA O4 S ST O4 i O4 i ST H2 ST ST O4 S O4 S
5 NOSAI Salmonella O4i Salmonella Typhimurium ST ST Salmonella. Dublin LPS ELISA ELISA ST Salmonella. Dublin O4i NOSAI Salmonella enterica O4 i O4 i Salmonella enterica Typhimurium ST ST O4 i O4 i O4 i O4 i O4 i
6 NOSAI LPS LPS B S A G TP AST CPK NOSAI NOSAI NOSAI NOSAI NOSAI OM Mycoplasma bovis M.bovis OM kg TS OM M.bovis Pasteurella µl g dl g dl DGkg M.bovis DG Ht OM OM OM M.bovis DG A G
7 NOSAI NOSAI NOSAI NOSAI NOSAI OM Mycoplasma bovis OM OM kg TS OM DG DGkg α β g OM OM Trueperella pyogenes Tp Fusobacterium necrophorum Fn Mycoplasma bovis Mb Mycoplasma dispar Tp Fn Fn Tp Mb RS Fn Tp
8 NOSAI NOSAI Mycoplasma Mycoplasma Prominence Fischer nm Mycoplasma nm p Mycoplasma nm p Mycoplasma Fischer p Fischer Mycoplasma ROC Mycoplasma Fischer Mp Mp Mycoplasma bovis M.bovigenitalium M.bg M.bg M.bg A B M.bg A B M.bg A B SDS-page PCR M.bg M.bg M.bg BamH1 A M.bg M.bg B M.bg M.bg M.bg M.bg M.bg M.bg M.bg M.bg
9 Streptococcus uberis ube OS ube Str. dysgalactiae dysgenterococcus faecalis fcae. faecium fci A B C D E F F S16 rrna PCR ube cm 2 fci fca fci g ube B C D A EF ube fci nn gg IgG1 BHV BVDV BVDV2 RS BRSVBRV BCV IgG1mg ml mg ml IgG1 mg ml IgG1mg ml BHV1 BVDV2 BRSV IgG1
10 NOSAI FPT failure of passive transfer FPT FPT IgG mg ml t Mann-Whitney U x Fisher Kruskal-Wallis FPT RBC µl µl PLT µl µl BUN mg dl mg dl T-Chomg dl mg dl IgG mg ml mg ml Sial mg dl mg dl GOTU l U l LDHU l U l kg kg cm cm RBC P P FPT NOSAI l
11 NOSAI F14 Cr BCV BRV Cr l l l l l BCV BRV Cr EX ET l EX kg kget kg kg EX cmcmet cmcm EX kgkget kgkg ET EX EX ET CP CP
12 A IU dl B1 B1 cm NOSAI kg Levine φ cm φ cm MRI CT cm cm φ cm φ cm MRI CT
13 NOSAI BUN CRE P BUN CRE P BLV BLV caudal vena cava thrombosis : CVCT CVCT CVCT pulmonary thromboembolism : PTE CVCT PTE PTE PTE A G PTE
14 NOSAI X PIXE : Particle Induced X-ray Emission Ecoli Klebsiella pneumonia PIXE Mann Whitney U PIXE Al As Br Ca Cl Co Cr Cu Fe Ga Hg K Mg Mn Mo Na Nb Ni P Pb Rb S Se Si Sr Ti V Y Zn Fe µg g µg g p Zn µg g µg g p PIXE Fe Zn Zn NF-kB Fe Fe PIXE NOSAI NOSAI NOSAI NOSAI Charles River Laboratories Fe 3+ Hepc IL 6 IL-6 Fe Fe 3+ µg kg O-111 B4 LPS Fe 3+ Fe 2+ Dunnett-t Echerichia coli Klebsiella pneumonia Fe 3+ post-hoc Kruskal-Wallis ROC Fe 3+ p P Fe 3+ µg dl µg ml p ROC Fe 3+ µg dl p Se Sp Fe 3+ Fe 3+ Fe 3+
15 NOSAI NOSAI NOSAI NOSAI Charles River Laboratories A SAA SAA µg kg O-111 B4 LPS SAA LATIA Dunnett-t Echerichia coli Klebsiella pneumonia SAA post-hoc Kruskal-Wallis ROC p p SAA µg ml µg ml p ROC SAA µg ml p Se Sp SAA SAA SAA SAA NOSAI Ca VitD3 Ca Mg OR CI SPSS ver Ca OR VitD3 OR VitD3 OR Ca OR VitD3OR Ca Ca VitD3 VitD3
16 NOSAI Ca P kg BCS ml IV ml SC ml ml VS Ca ica ip Mg Ca IV mg dl SC mg dl VS mg dl ica Ca ip IV mg dl SC mg dll VS mg dl Mg IV Ca SC VS Ca ica IV SC VS SC VS K K K K T T K K K EP AB K meq l K meq l K meq l K K meq l K K P T T P T P K K K P mv T mv T P P T T P K T P K K T P rp K K K T P K
17 NOSAI VS VS Ket BHBA µmol l Mas Ute VS VS VS VS VS DIM p VS Ket Mas Ute Mas VS Ket Ute Mas VS DIM VS Mas DIM DIM VS VS VS VS NOSAI LCP DCPLCP LCP kg LCP LCP mm mm mmmm mm Lag LCP mg kg ml kg LCP LCP
18 NOSAI Velpeau Velpeau Velpeau Velpeau Velpeau Velpeau Velpeau kg mmhg mm
19 VF NOSAI kg kgkg mm V V cm BToV BToV RT-PCR HRT18aichi BToV spike Smembrane Mhemagglutinin-esterase HE nucleocapsid N BToV BToV BToV S M N S HE GM BToV BToV S HE BToV BToV GM BToV
20 NOSAI FNA cm WBC µl µl LDH U l TK U l kg TK
21 BLV BLV BLV ELISA PCR PCR PCR DNA DNA Wizard Genomic DNA Purification Kit, Promega DNA NestedPCR BLV BLV BLV BLV PCR KOD FX Neo Toyobo BLV PCR BLV NestedPCR KOD FX Neo PCR KOD FX Neo DNA BLV PCR rpcr rpcr ELISA rpcr rpcr rpcr rpcr rpcr rpcr
22 PCR rpcr rpcr L T L T L T L L T T rpcr L L T pg well pg well T pg well pg well rpcr rpcr rpcr rpcr rpcr NOSAI M M Ht M M
23 NOSAI M M M Theileria orientalis T.o PCR PCR T.o T.o T.o T.o M BSE BSE BSE BSE BSE BSE BSE L BSE BSE JP24 BSE BSE EX-ZR300 Move-tr 2D TMT441E BSE BSE BSE BSE
24 Clostridium perfringenscp CP A CFU g CP α C CP CP CP CP CP CP CP CP NOSAI D S D S G G G G D S
25 NOSAI X X X X NOSAI NSAIDs NSAIDs NSAIDs NSAIDs NSAIDs mg kg ivmg NSAIDs NSAIDs NSAIDs NSAIDs NSAIDs
26 NOSAI NOSAI JA Student t 1stDF1stDF 1stDF 1stDF E2 E2 E2 1stDF 1stDF 1stDF 1stDF 1stDF 1stDF 1stDF P vs 1stDF P vs 1stDF 1stDF 1stDF
27 NOSAI TAI Day0 mg PGimDay2µg Gn im Day9 PG im Day11 Gn im Day12 TAI TAI AI TAI TAI TAI AI TAI P ORCI AI P OR CI TAI NOSAI CIDR CIDR DF ; Dominant Follicle CIDR DF CIDR EBmg PGF2αmg CIDR DF EB mg AI CIDR DFmm CIDR mm DF EB AI second EB χ DF DFmmmm DF mm mm DF DF DFmmmm DF mm mm DF mm DF mm pp second EB DFmmp EB DF mm mm EB SE CIDR DF mmmmmmmmmm CIDR CIDR DF CIDR DFmm second EB EB second EB
28 NOSAI CIDR P4 g P4 CIDR P4 CIDR New n CIDR Used n CIDR-synch Day0 CIDR mg Day8 CIDR Day9mg Day10-11 AIDay0 1 7 P4Day0 7 CIDR New n CIDR Used n CIDR-synch Day7 PGF2αmg P4 SD ng ml Day0 1 7 New Used New Used New Used Used Day0 New Used CIDR P4ng ml CIDR P4 P4 Used P4 CIDR P4 NOSAI VWP
29 NOSAI n n vs p vs p vs Y cm cm WW PG 2W 3W 2W 3W 2W 3W SD 2W cm 3W cm 2W 2W 3W 2W cm 3W cm 2W 3W PG
30 l NOSAI A A R A NEFA mmol l BHBA mmol l BCS A NEFA vs mmol l p BHBA BCS NEFA r BHBA r A NEFA mmol l BHBA BCS BHBA NEFA
31 NOSAI T Student t χ p NOSAI NOSAI NOSAI F kgkg Fkg cm cm Fcm cmcm Fcm ml g g g Fg g g g F gg gg Fg gg g Fgggg Fg F F α CK IU l CK
32 ELISA Mann-Whitney U SPSS12.0J P Dairy Comp 305 Valley Agricultural software SPSS12.0J p BCS
33 NOSAI Carroll and Huntington NOSAI Carroll and Huntington p p nkg kg kg nkg kg kg nkg kg kg nkg kg kg
34 µg kgmg kgmg kg CRImg kg min mg kg K meq l ph K K meq l meq l CRI K K Na K mm cm cm cm PDS
35 NOSAI BCS limb perfusion cm X NOSAI X X MLBT-TIVA X
36 BTC Staphylococcus aureus Streptococcus equi Acinetobacter lwoffii Staphylococcus xylosus Staphylococcus vitulinus Enterobacter agglomerans Flavimonas oryzihabitans Staphylococcus sciuri JRA CFUµl PFU µl
37 C mm C MMC MMC mg ml ml C US US US US US US US Renosplenic Entrapment RE RE US US US US US
38 X-ray US US US US AAEP lameness grading MHz MHz X-ray US US US X-ray US US US X-ray X-ray US US US X ray US X HP http : //www. hba.or.jp/rep/onegai.pdf X Jackson Grade1 Grade2Grade3 Grade Grade Grade1 Grade2 Grade3 Grade2 Grade3 Grade3 Grade3 Grade3 Grade3 Jackson Grade1
39 CT CT CT kg CT CT CT Brightspeed Elite, GE Healthcere, Japan CT cm mmmm mm mm CT Tenoscopy Tenoscopy
40 Cre22 mg dl BUN31 mg dl Cre18 mg dl BUN42 mg dl K5.5 meq l PAS Luxol fast blue Concanavalin A wheat germ agglutinin Ricinus communis agglutinin 120 soybean agglutinin
41 Mycobacterium M. avium-intracellure complex
42 NOSAI Lawsonia intracellularis Li PCR BTHRbpm RR bpm SAA PCR Li BTHRbpm SAA PCR Li Li Li PCR JRA Lawsonia intracellularis Li EPE Li Li PPE EPE PPE Boehringer Ingelheim McCoy Li B3903 TCID50ml ml PCR Li PPE EPE EPE EPE EPE PCR EPE PCR PPE PPE PPE
43 nn n nn n n nnn n D L WI BL NLL D Ki-67 E-Cadherin IHC Ki-67 L D WI BL NL WI n nn n nl D WI BL NL D WI L WI IHC E- Cadherin Ki-67 Ki-67 L D WI BL NL WI Ki-67
44 S mm mm n mm n Ishii Ishii G1 G2 G3 G2 G3 G2 G3 G2 G1 G2 G3
45 G ml NOSAI
46 NOSAI GPS ATP ATP A B ATP x ml A B ml AB A BA:PB:P A B ml A B P A B P ATP logrlu A B A B A A ATP
47 vicugna pacos µg kg Sarcoptes scabiei var aucheniae µg kg O.P cm PRRS surface protective antigen type A SpaA SpaA SpaA
48 Salmonella sp. O4 io4 i - O4 i O4 i Salmonella TyphimuriumST O4 i ST A B C O4 i ST O4 i O4 i A B ST ST C O4 ia B A B O4 i O4 Salmonella O4 O4 ST O4 i O4 A B O4 i O4 i ST O4 i ST PCMV PCMV PCMV CPK PK-15 PCMV PCMV PCMV IgG PCMV
49 A PCV2 Salmonella O4 i PCV2 Salmonella O4 i
NOSAI NOSAI
F NOSAI NOSAI F F NOSAI NOSAI F NOSAI NOSAI NOSAI NOSAI NOSAI NOSAI Computed Radiography CR X Computed Radiography System FCR PRIMA T X PORTA 380HF GT GC GS RNRTREDRN DRTDRE IP GS RE IP CR NOSAI HH mm
More informationNOSAI NOSAI
C C NOSAI NOSAI NOSAI NOSAI NOSAI C C NOSAI NOSAI NOSAI NOSAI NOSAI NOSAI Computed Radiography CR X NOSAI NOSAI CR NOAI DICOM OSIRIX S S S S S S X IP S S S S X T4 Vertebral Heart Size VHS VHS VHS n WCS
More information36 th IChO : - 3 ( ) , G O O D L U C K final 1
36 th ICh - - 5 - - : - 3 ( ) - 169 - -, - - - - - - - G D L U C K final 1 1 1.01 2 e 4.00 3 Li 6.94 4 Be 9.01 5 B 10.81 6 C 12.01 7 N 14.01 8 16.00 9 F 19.00 10 Ne 20.18 11 Na 22.99 12 Mg 24.31 Periodic
More informationIS(A3) 核データ表 ( 内部転換 オージェ電子 ) No.e1 By IsoShieldJP 番号 核種核種半減期エネルギー放出割合核種番号通番数値単位 (kev) (%) 核崩壊型 娘核種 MG H β-/ce K A
IS(A3)- 284 - No.e1 核種核種半減期エネルギー放出割合核種通番数値単位 (kev) (%) 1 1 1 MG-28 20.915 H 29.08 27.0000 β-/ce K Al-28 2 1 2 MG-28 20.915 H 30.64 2.6000 β-/ce L Al-28 3 2 1 SC-44M 58.6 H 270.84 0.0828 EC/CE CA-44 4 2
More informationuntitled
NPO 2006( ) 11 14 ( ) (2006/12/3) 1 50% % - - (CO+H2) ( ) 6 44 1) --- 2) ( CO H2 ) 2 3 3 90 3 3 2 3 2004 ( ) 1 1 4 1 20% 5 ( ) ( ) 2 6 MAWERA ) MAWERA ( ) ( ) 7 6MW -- 175kW 8 ( ) 900 10 2 2 2 9 -- - 10
More information物理化学I-第12回(13).ppt
I- 12-1 11 11.1 2Mg(s) + O 2 (g) 2MgO(s) [Mg 2+ O 2 ] Zn(s) + Cu 2+ (aq) Zn 2+ (aq) + Cu(s) - 2Mg(s) 2Mg 2+ (s) + 4e +) O 2 (g) + 4e 2O 2 (s) 2Mg(s) + O 2 (g) 2MgO(s) Zn(s) Zn 2+ (aq) + 2e +) Cu 2+ (aq)
More information03J_sources.key
Radiation Detection & Measurement (1) (2) (3) (4)1 MeV ( ) 10 9 m 10 7 m 10 10 m < 10 18 m X 10 15 m 10 15 m ......... (isotope)...... (isotone)......... (isobar) 1 1 1 0 1 2 1 2 3 99.985% 0.015% ~0% E
More informationMast Cell Tumor : MCT c-kit MCT F F MCT C c-kit DNA Canine DNA Ver DNA c-kit C c 1275 A G F c.2355 G A DNA F C F C c-kit MCT c-kit DNA MCT Kiel T B kg cm T T Stage a UW25 P MDR1 B L T B L Leptospira L
More information2 1 7 - TALK ABOUT 21 μ TALK ABOUT 21 Ag As Se 2. 2. 2. Ag As Se 1 2 3 4 5 6 7 8 9 1 1 2 3 4 5 6 7 8 9 1 1 2 3 4 5 6 7 8 9 1 Sb Ga Te 2. Sb 2. Ga 2. Te 1 2 3 4 5 6 7 8 9 1 1 2 3 4 5 6 7 8 9 1 1 2 3 4
More informationコロイド化学と界面化学
x 25 1 kg 1 kg = 1 l mmol dm -3 ----- 1000 mg CO 2 -------------------------------------250 mg Li + --------------------------------1 mg Sr 2+ -------------------- 10
More information4 1 Ampère 4 2 Ampere 31
4. 2 2 Coulomb 2 2 2 ( ) electricity 2 30 4 1 Ampère 4 2 Ampere 31 NS 2 Fleming 4 3 B I r 4 1 0 1.257 10-2 Gm/A µ 0I B = 2πr 4 1 32 4 4 A A A A 4 4 10 9 1 2 12 13 14 4 1 16 4 1 CH 2 =CH 2 28.0313 28 2
More informationMP-AES ICP-QQQ Agilent 5100 ICP-OES Agilent 5100 (SVDV) ICP-OES (DSC) 1 5100 SVDV ICP-OES VistaChip II CCD Agilent 7900 ICP-MS 7700 / 10 7900 ICP-MS ICP-MS FTIR Agilent 7900 ICP-MS Agilent Cary 7000 (UMS)
More information1 1 H Li Be Na M g B A l C S i N P O S F He N Cl A e K Ca S c T i V C Mn Fe Co Ni Cu Zn Ga Ge As Se B K Rb S Y Z Nb Mo Tc Ru Rh Pd Ag Cd In Sn Sb T e
No. 1 1 1 H Li Be Na M g B A l C S i N P O S F He N Cl A e K Ca S c T i V C Mn Fe Co Ni Cu Zn Ga Ge As Se B K Rb S Y Z Nb Mo Tc Ru Rh Pd Ag Cd In Sn Sb T e I X e Cs Ba F Ra Hf Ta W Re Os I Rf Db Sg Bh
More information42 3 u = (37) MeV/c 2 (3.4) [1] u amu m p m n [1] m H [2] m p = (4) MeV/c 2 = (13) u m n = (4) MeV/c 2 =
3 3.1 3.1.1 kg m s J = kg m 2 s 2 MeV MeV [1] 1MeV=1 6 ev = 1.62 176 462 (63) 1 13 J (3.1) [1] 1MeV/c 2 =1.782 661 731 (7) 1 3 kg (3.2) c =1 MeV (atomic mass unit) 12 C u = 1 12 M(12 C) (3.3) 41 42 3 u
More information(1) ) ) (2) (3) (4) (5) (1) (2) b (3)..
... -1... -1... -2... -6.... -1 (1)... -1 1)... -1 2)... -14 (2)... -19 (3)... -52 (4)... -18 (5)... -136.... -196 (1)... -196 (2) b... -224 (3)... -233.... -251.... -286.... -289 (1)... -289 (2)... -32
More informationJAJP
Agilent 7500ce ORS ICP-MS Glenn Woods Agilent Technologies Ltd. 5500 Lakeside, Cheadle Royal Business Park Stockport UK Agilent 7500ce ICP-MS 5 7500ce (ORS) 1 ORS 7500ce ORS ICP-MS ( ) 7500 ICP-MS (27.12
More information125 2 P 1st washout 2 PB P mg/dL nd washout 2 P 5.5mg/dL< mg/dL <2.5mg/dL P P 2 D D 3 Ca 10
. (1) 125 1 125 Renagel PB-94 P intact-pth P 1 b c a b 1 18 2 3 3 3 1 P 4 D 1 5 6 7 2 1HIV 2 3 4 5Hb 8.0g/dL ALT 48IU/L 6 7 PB-94 440mg 403mg 1-196 125 2 P 1st washout 2 PB-94 1 2 4 4 P 2.5 5.5mg/dL 1
More information元素分析
: このマークが付してある著作物は 第三者が有する著作物ですので 同著作物の再使用 同著作物の二次的著作物の創作等については 著作権者より直接使用許諾を得る必要があります (PET) 1 18 1 18 H 2 13 14 15 16 17 He 1 2 Li Be B C N O F Ne 3 4 5 6 7 8 9 10 Na Mg 3 4 5 6 7 8 9 10 11 12 Al Si P
More informationRAA-05(201604)MRA対応製品ver6
M R A 対 応 製 品 ISO/IEC 17025 ISO/IEC 17025は 試験所及び校正機関が特定の試験又は 校正を実施する能力があるものとして認定を 受けようとする場合の一般要求事項を規定した国際規格 国際相互承認 MRA Mutual Recognition Arrangement 相互承認協定 とは 試験 検査を実施する試験所 検査機関を認定する国際組織として ILAC 国際試験所認定協力機構
More informationッ ー ー ー() () 2.5 () () 21 1) -1 2) -2 10 m 5 7 23 6 1)2) 3) -1-2 H23.4.25 -15-20 4 75 5 1) -1 (5) (3) (3) (2) (1) (1) (1) (1) (1) (1) (1) (1) (1) (1) (1) (1) 1) ( 23 6 8 ) 2) 22 3)
More information2001 Mg-Zn-Y LPSO(Long Period Stacking Order) Mg,,,. LPSO ( ), Mg, Zn,Y. Mg Zn, Y fcc( ) L1 2. LPSO Mg,., Mg L1 2, Zn,Y,, Y.,, Zn, Y Mg. Zn,Y., 926, 1
Mg-LPSO 2566 2016 3 2001 Mg-Zn-Y LPSO(Long Period Stacking Order) Mg,,,. LPSO ( ), Mg, Zn,Y. Mg Zn, Y fcc( ) L1 2. LPSO Mg,., Mg L1 2, Zn,Y,, Y.,, Zn, Y Mg. Zn,Y., 926, 1 1,.,,., 1 C 8, 2 A 9.., Zn,Y,.
More informationH1-H4
42 S H He Li H He Li Be B C N O F Ne Be B C N O F Ne H He Li Be B H H e L i Na Mg Al Si S Cl Ar Na Mg Al Si S Cl Ar C N O F Ne Na Be B C N O F Ne Na K Sc T i V C r K Sc Ti V Cr M n F e C o N i Mn Fe Mg
More information1/120 別表第 1(6 8 及び10 関係 ) 放射性物質の種類が明らかで かつ 一種類である場合の放射線業務従事者の呼吸する空気中の放射性物質の濃度限度等 添付 第一欄第二欄第三欄第四欄第五欄第六欄 放射性物質の種類 吸入摂取した 経口摂取した 放射線業 周辺監視 周辺監視 場合の実効線 場合
1/120 別表第 1(6 8 及び10 関係 ) 放射性物質の種類が明らかで かつ 一種類である場合の放射線業務従事者の呼吸する空気中の放射性物質の濃度限度等 添付 第一欄第二欄第三欄第四欄第五欄第六欄 放射性物質の種類 吸入摂取した 経口摂取した 放射線業 周辺監視 周辺監視 場合の実効線 場合の実効線 務従事者 区域外の 区域外の 量係数 量係数 の呼吸す 空気中の 水中の濃 る空気中 濃度限度
More informationC VECS C F M kg A E W kg I A R. R. Gkg MGD MGD MGD MGD SPKMGD MGD MGD SPK SPK MGD MMP MMP MMP kg mmhg Intrascleral prosthesis : ISPISP ISP ISP ISP ISP ISP ISP ISP ISP mm mm ISP mm min mm min ISP mm min
More informationiii 1 1 1 1................................ 1 2.......................... 3 3.............................. 5 4................................ 7 5................................ 9 6............................
More information13 0 1 1 4 11 4 12 5 13 6 2 10 21 10 22 14 3 20 31 20 32 25 33 28 4 31 41 32 42 34 43 38 5 41 51 41 52 43 53 54 6 57 61 57 62 60 70 0 Gauss a, b, c x, y f(x, y) = ax 2 + bxy + cy 2 = x y a b/2 b/2 c x
More informationw i6505.j
MHz 384 Mp Mycoplasma californicum Mycoplasma bovigenitalium Mp Mp / Mp PCR Mp / M. californicum M. bovigenitalium Mp Mp Mp Mp g OTC OTC 385 Mp Mp Mp M. californicum M. bovigenitalium Mp Mp / Mp M. californicum
More informationuntitled
, Kaoru ARIYAMA 10 17N, Na, Mg,Al,Si,P,S,Cl,K,Ca,Fe,Cu,Zn,Se,Br,Rb Sr 14r2 0.9617 Tricholoma matsutake,,, JAS ICP-OESICP-MS 2ICP-OES ICP-MS,, Tricholoma matsutake -24- 1 7 2006 70 13 8 5 2,, 2007,, 10
More information2010 年 6 月 25 表 身体所見 134 cm 31 kg /60 mmhg 83/ ,
24 シンポジウム Ⅲ 要旨 NPPV NPPV 緒 IPF 4 5 1 IPF 2004 2 QOL 179 10 現 10 18 2008 10 言 状 3.4 8.3 76.2 41 37.2 13.6 3 1 症 例 呈 示症例 患者 61 主訴 既往歴 30 45 家族歴 喫煙歴 飲酒歴 職歴 現病歴 13 NSIP 15 1 HOT 15 7 2010 年 6 月 25 表 1 1998
More information温泉の化学 1
H O 1,003 516 149 124 2,237 1974 90 110 1km 2,400 ( 100 Mg 200 (98 ) 43,665 mg 38,695 mg 19,000 mg 2000 2000 Na-Ca-Cl 806 1970 1989 10 1991 4 ph 1 981 10,000 1993... (^^; (SO_4^{2-}) " " 1973-1987 1970
More informationbrother.\..2.ai
2004.3 95 pc 2 5 6 7 8 Q SC-370pc 9 HG-2614977766611312 HG-2514977766611329 HG-2414977766611336 HG-2314977766611343 HG-2214977766611350 HG-2114977766611367 TZ-FX2514977766621236 TZ-FX2414977766621229
More information/ B B ( ) ( -298) VL VH( ) Very Low( ) Very High( ) ( 10 2 %) (g/l) ( 10 2 %) 0.75 ( 10 2 %) 0.15 ( 10 2 %)
/ B B ( ) ( -298) VL VH( ) Very Low( ) Very High( ) (10 2 %) 0.32 0.55 0.37 0.55 95 165 115 185 (10 2 %) 0.75 (10 2 %) 0.15 (10 2 %) 0.10 10 2 % 0.10 10 2 % 0.15 10 2 % 0.10 Bands(10 2 %) 0.10 (10 9 75
More informationX線分析の進歩36 別刷
X X X-Ray Fluorescence Analysis on Environmental Standard Reference Materials with a Dry Battery X-Ray Generator Hideshi ISHII, Hiroya MIYAUCHI, Tadashi HIOKI and Jun KAWAI Copyright The Discussion Group
More informationRN201602_cs5_0122.indd
ISSN 1349-1229 No.416 February 2016 2 SPECIAL TOPIC113 SPECIAL TOPIC 113 FACE Mykinso 113 SPECIAL TOPIC IUPAC 11320151231 RI RIBFRILAC 20039Zn30 Bi83 20047113 20054201283 113 1133 Bh107 20082009 113 113
More informationhv (%) (nm) 2
HOLLOW CATHODE LAMPS hv 1 2 1 8 5 3 4 6 (%) 6 4 7 8 2 16 2 24 28 32 36 4 44 (nm) 2 1 328.7 346.5 Ag 47-47NB(AG) 338.28 1 2 Re 75-75NB(RE) 346.47 2 25 39.27 343.49 Al 13-13NB(AL) 396.15 1 2 Rh 45-45NB(RH)
More information橡H141(成人モニタリング12年まとめ)表紙・目次・
2 12 C NO2SPM C 10 1 V25 NOx 1 10836 NOx 0.767ppm 13860 NOx 0.703ppm (3) 33562 NOx 0.710ppm (4) 33432 NOx 0.800ppm (5) 15392 NOx 0.611ppm (6) 9263 NOx 0.508ppm (7) 8165 NOx 0.284ppm - 1 - (8) 10866 NOx
More informationAgilent AA ICP ICP-MS ICP-MS AA 55B AA LCD AA PC PC 240 AA / / AA 240FS/280FS AA AA FS 240Z/280Z AA GFAA AA Duo 1 PC AA 2 280FS AA
Agilent Agilent AA 195750 ICP ICP-MS ICP-MS AA 55B AA LCD AA PC PC 240 AA / / AA 240FS/280FS AA AA FS 240Z/280Z AA GFAA AA Duo 1 PC AA 2 280FS AA 1938 HP 1965 HP 1976 GC/MS HP 5992A 1983 GC GC HP 5890A
More informationuntitled
1 ... 3... 3... 3... 4...13...16...18...20...22 2 PTPE 3 PTPE CT Grade 2 A PTPE PTPE 4 A S 3 3 B H3,P1,N1,M1, LM0, R23 15 20gS, ptype 3, 60 x 50mm, pt4b/siurinary bladder, int, INF, ly2, v1, ppm070mm,
More information後期化学_01_濃度
2011 ( ) 1 4 1 100 g g % * 1 100 g 1 g 1 % * 2 (1 g)/(100 g) = 0.01 = 1 % 100 g 100 g 99 g 100 g 1 g 1 % 2.5 g 50 g (2.5 g)/(50 g) = 0.050 = 5.0 % 100 ml g 1 %(w/w) wt% % %(w/v) % / 2 % SI 2 / % 100 ml
More information汎用商品総合カタログ.indd
汎用商品 総合カタログ 1 2 3 INDEX 39 2way 1 #04920 68 AU 333ml CR #40111 1213m55mm 68 AU 333ml CR #40110 1213m55mm 13 500g #40117 14 K 6804 CH18 1kg #40127 150200g P A 5538 3kg #40140 14 CH18 5kg P #40177 K 6804
More information2 Zn Zn + MnO 2 () 2 O 2 2 H2 O + O 2 O 2 MnO 2 2 KClO 3 2 KCl + 3 O 2 O 3 or 3 O 2 2 O 3 N 2 () NH 4 NO 2 2 O + N 2 ( ) MnO HCl Mn O + CaCl(ClO
1 [1]. Zn + 2 H + Zn 2+,. K Ca Na Mg Al Zn Fe Ni Sn Pb H Cu Hg Ag Pt Au H (H + ),,. [2] ( ) ( ) CO 2, S, SO 2, NH 3 () + () () + () FeS Fe S ( ) + ( ) ( ) + ( ) 2 NH 4 Cl + Ca(OH) 2 Ca O + 2 NH 3,.,,.,,.,.
More information入試の軌跡
4 y O x 4 Typed by L A TEX ε ) ) ) 6 4 ) 4 75 ) http://kumamoto.s.xrea.com/plan/.. PDF) Ctrl +L) Ctrl +) Ctrl + Ctrl + ) ) Alt + ) Alt + ) ESC. http://kumamoto.s.xrea.com/nyusi/kumadai kiseki ri i.pdf
More information1.2 M N M d- BBB / ChE etc ChE etc CCh BCh etc Ach ChE 2 Ach ChE PAM ChE
1 - d- etc etc d-tc ChE > < < < > > > or 1.1 1 d- < dtc Na + Na + I II ChE ChE ChE ( ) T Ca++ 1 Na + K + Na + Ach Ach Ach BTX Mg 2+ Ach CAT TTX Ach 1.2 M N M d- BBB / ChE etc ChE etc CCh BCh etc Ach ChE
More informationuntitled
ver. 3.3JT EVENING PRIMROSE EXTRACT 1 - PMS 1 2 1 4 Oenothera laciniata Oenothera striata Oenothera biennis Oenothera erythrosepala - 2 80 60 40 20 0 1. 2 3 PGGPAC 2. 3 4 ESR3.5 10 5 /g 4 3 1 Helicobacter
More information1 Ricci V, V i, W f : V W f f(v ) = Imf W ( ) f : V 1 V k W 1
1 Ricci V, V i, W f : V W f f(v = Imf W ( f : V 1 V k W 1 {f(v 1,, v k v i V i } W < Imf > < > f W V, V i, W f : U V L(U; V f : V 1 V r W L(V 1,, V r ; W L(V 1,, V r ; W (f + g(v 1,, v r = f(v 1,, v r
More information4. 5.
1. 2. 20 3. 4. 5. ) N ) 6. ) 7. 8. JA 1. 30 CO2 18 2. 20 3. 4. 5. 5.1 cm 5.2 5.2.1 1 17kg 119kg11 5.2.2 60 750 2 2 5.2.3 30m 5.2.4 3 200g 6. 1 500 200 3 2 16 600 21 /10067kg/198kg10037 2025 3 4 3 3 6 102
More informationCRA3689A
AVIC-DRZ90 AVIC-DRZ80 2 3 4 5 66 7 88 9 10 10 10 11 12 13 14 15 1 1 0 OPEN ANGLE REMOTE WIDE SET UP AVIC-DRZ90 SOURCE OFF AV CONTROL MIC 2 16 17 1 2 0 0 1 AVIC-DRZ90 2 3 4 OPEN ANGLE REMOTE SOURCE OFF
More information無印良品 2012 自転車 カタログ
26 897895321,000 140cm 76.0cm 16.0kg H LED 3 263 897896025,000 140cm 76.0cm 16.5kg H 3 LED 20 8978984 8978977 19,800 134cm 73.0cm 15.0kg LED 2620 2620 8486656550 5536207483 14512372,100 8279999840 26 77342561,417
More information2 6 8 10 12 14 18 20 22 24 26 29 32 34 36 1 40 42 44 39 47 48 50 52 54 56 58 60 62 64 68 70 72 74 76 78 80 67 83 84 86 88 90 92 94 96 97 98 100 102 103 104 106 110 112 114 116 118 120 122 124 126 128 130
More informationx, y x 3 y xy 3 x 2 y + xy 2 x 3 + y 3 = x 3 y xy 3 x 2 y + xy 2 x 3 + y 3 = 15 xy (x y) (x + y) xy (x y) (x y) ( x 2 + xy + y 2) = 15 (x y)
x, y x 3 y xy 3 x 2 y + xy 2 x 3 + y 3 = 15 1 1977 x 3 y xy 3 x 2 y + xy 2 x 3 + y 3 = 15 xy (x y) (x + y) xy (x y) (x y) ( x 2 + xy + y 2) = 15 (x y) ( x 2 y + xy 2 x 2 2xy y 2) = 15 (x y) (x + y) (xy
More information000..\..
Bull. Nagoya Univ. Museum No. 20, 79 91, 2004 Quantitative chemical analysis of rocks with X-ray fluorescence analyzer XRF-1800 NAKAZAKI Mineko TSUBOI Motohiro KANAGAWA Kazuyo KATO Takenori SUZUKI Kazuhiro
More information381
P381 P386 P396 P397 P401 P423 P430 P433 P435 P437 P448 P451 P452 381 382 383 384 385 3.0mm 5.0mm 3.0mm 5.0mm SK SK3.0mm SK5.0mm 3.0mm PUR PUR3.0mm 2.0mm 2.0mm3.0mm 2.5mm 2.5mm3.0mm 3.0mm 5.0mm 3.0mm 1.8mm
More informationuntitled
DiBartola SP DiBartola SP 1987 Elliott Elliott J 1998 Elliott J 2000 Elliott J 2003 Part 1 24 0.75 70 1.3 1.3 2.0 1/2 2 6 1/2 22 18 Part 2003 Dr Chew 1 2 2 3 Part Cre Cre 1 Part Cre 2% 0.1ml/kg 0.3ml/kg
More information- 1 - - 2 - - 3 - - 4 - - 5 - - 6 - - 7 - - 8 - - 9 - - 10 - - 11 - - 12 - - 13 - - 14 - - 15 - - 16 - - 17-54 55 56 57 58 ( ) 54 7 55 56 57 58 10 54 55 57 58 56 25 27 25 27 20 22 25 22 1.4g 23 23 :1.8g
More information第十五改正日本薬局方第一追補
316 3 5 7 9 9 9 12 13 14 14 14 23 23 23 24 24 29 29 29 35 37 131 161 173 193 194 198 200 205 3 37 37 37 38 38 38 39 39 40 40 41 42 43 43 45 46 47 48 49 50 51 52 52 53 54 54 54 55 56 58 58 59 60 60 61 61
More informationE82/E87/E88 BMW Brake Pad Matching List GLAD Model Model No. Year Front Rear etc 116i UF16 / UE F#148 R# i UF F#148 R#
E82/E87/E88 No. Year Front Rear etc 116i UF16 / UE16 04-11 F#148 R#146 118i UF18 04-11 F#148 R#146 04-06 F#145 UF20 120i 06-07 F#148 R#146 UD20 07-11 F#187 120i Coupe / Cabriolet UC20 / UL20 08-11 F#187
More informationuntitled
Metabolic syndrome,,,, 81 81 , 17 17 2 Lung Ca non small cell carcinoma / / food( food( ) drug( drug( ) 100mg 750mg WBC 5510/ l RBC 483 / l Hb 10.3g/dl, Ht 42.0% Plt 19.0 / l TP 8.1g/dl Alb 4.6g/dl Glb
More information& IT/ IT
C O R P O R A T E O U T L I N E 2 8 &-3 25 9 1 1 IT/7 1 2 3 4 6 8 1 11 12 13 14 16 2 21 22 IT 24 25 28 32 34 36 37 38 39 4 41 42 43 44 45 46 &HLDGS. &HLDGS. &HLDGS.1 35, 13, 2,8 1,4 76 97 69-6 7 3 2 2
More information2_R_新技術説明会(佐々木)
% U: 6.58%, Np, Am:.5%, Pu:.% 5.8% Cs 6.5% Sr %.9%Mo 8.74% Tc.9% TODA C 8 H 7 C 8 H 7 N CH C CH N CH O C C 8 H 7 O N MIDOA C 8 H 7 DOODA NTA + HN(C 8 H 7 ) + H O DCC + SOCl + HN(C 8 H 7 ) + Cl TODA (TODA)
More information?
240-8501 79-2 Email: nakamoto@ynu.ac.jp 1 3 1.1...................................... 3 1.2?................................. 6 1.3..................................... 8 1.4.......................................
More informationPowerPoint プレゼンテーション
2004 3 3 2 3 4 5 6 7 8 9 10 T. Ito, A. Yamamoto, et al., J. Chem. Soc., Chem. Commun., 136 (1974) J. Chem. Soc., Dalton Trans., 1783 (1974) J. Chem. Soc., Dalton Trans., 1398 (1975) 11 T.Ito, A. Yamamoto,
More information2 129-B*-006P 129-B*-007P C*-004P 129-D*-001P ADH B*-006P B*-007P C*-004P D*-001P Na
2.7.4 2.7.4.1 2.7.4.1.1 11 ADH 1 ADH 1 4 7 129-A*-003 129-B*-001 129-E*-001P 129-G*-001 129-H*-002 129-H*-004 129-H*-005 132 242 4 129-B*-004 129-C*-005P 129-H*-003 129-H*-006 44 ADH ADH 129-C*-001P 16
More information1/68 A. 電気所 ( 発電所, 変電所, 配電塔 ) における変圧器の空き容量一覧 平成 31 年 3 月 6 日現在 < 留意事項 > (1) 空容量は目安であり 系統接続の前には 接続検討のお申込みによる詳細検討が必要となります その結果 空容量が変更となる場合があります (2) 特に記載
1/68 A. 電気所 ( 発電所, 変電所, 配電塔 ) における変圧器の空き容量一覧 平成 31 年 3 月 6 日現在 < 留意事項 > (1) 空容量は目安であり 系統接続の前には 接続検討のお申込みによる詳細検討が必要となります その結果 空容量が変更となる場合があります (2) 特に記載のない限り 熱容量を考慮した空き容量を記載しております その他の要因 ( 電圧や系統安定度など ) で連系制約が発生する場合があります
More information-------------------------------------------------------------------------------------------------- 1 ----------------------------------------- 3 --------------------------------------------------------------------------------
More informationX G P G (X) G BG [X, BG] S 2 2 2 S 2 2 S 2 = { (x 1, x 2, x 3 ) R 3 x 2 1 + x 2 2 + x 2 3 = 1 } R 3 S 2 S 2 v x S 2 x x v(x) T x S 2 T x S 2 S 2 x T x S 2 = { ξ R 3 x ξ } R 3 T x S 2 S 2 x x T x S 2
More informationprime number theorem
For Tutor MeBio ζ Eite by kamei MeBio 7.8.3 : Bernoulli Bernoulli 4 Bernoulli....................................................................................... 4 Bernoulli............................................................................
More informationgtf Wnt5a-Ror2 IL-8 in vitro Ozony Tron P. gingivalis SOD ELISA Location of main occluding areas and masticatory ability in patients with reduced occlusal support 12-Methacryloyloxydodecylpyridinium bromide
More information2008/02/18 08:40-10:10, 12:50-14:20 14:30-16:00, 16:10-17:40,
008/0/18 08:40-10:10, 1:50-14:0 14:30-16:00, 16:10-17:40, 1pt A 1911 Leiden Heike Kammelingh-Onnes H.Kammelingh Onnes 1907 He 1 4. K H H c T c T H c Hg:40 mt, Pb:80 mt, Sn:30 mt 100 mt I c H c H c H
More informationD 24 D D D
5 Paper I.R. 2001 5 Paper HP Paper 5 3 5.1................................................... 3 5.2.................................................... 4 5.3.......................................... 6
More information(1) θ a = 5(cm) θ c = 4(cm) b = 3(cm) (2) ABC A A BC AD 10cm BC B D C 99 (1) A B 10m O AOB 37 sin 37 = cos 37 = tan 37
4. 98 () θ a = 5(cm) θ c = 4(cm) b = (cm) () D 0cm 0 60 D 99 () 0m O O 7 sin 7 = 0.60 cos 7 = 0.799 tan 7 = 0.754 () xkm km R km 00 () θ cos θ = sin θ = () θ sin θ = 4 tan θ = () 0 < x < 90 tan x = 4 sin
More informationuntitled
- 1 - - 2 - - 3 - - 4 - - 5 - - 6 - - 7 - - 8 - - 9 - - 10 - - 11 - - 12 - - 13 - - 14 - - 15 - - 16 - - 17 - - 18 - - 19 - - 20 - - 21 - - 22 - - 23 - - 24 - - 25 - - 26 - - 27 - - 28 - - 29 - - 30 -
More information( ) Note (e ) (µ ) (τ ) ( (ν e,e ) e- (ν µ, µ ) µ- (ν τ,τ ) τ- ) ( ) ( ) (SU(2) ) (W +,Z 0,W ) * 1) 3 * 2) [ ] [ ] [ ] ν e ν µ ν τ e
( ) Note 3 19 12 13 8 8.1 (e ) (µ ) (τ ) ( (ν e,e ) e- (ν µ, µ ) µ- (ν τ,τ ) τ- ) ( ) ( ) (SU(2) ) (W +,Z 0,W ) * 1) 3 * 2) [ ] [ ] [ ] ν e ν µ ν τ e µ τ, e R, µ R, τ R (1a) L ( ) ) * 3) W Z 1/2 ( - )
More information- - - - - - - - - - - - - - - - - - - - - - - Babesia gibsoni - Babesia gibsoni - Babesia gibsoni - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
More information( )
18 10 01 ( ) 1 2018 4 1.1 2018............................... 4 1.2 2018......................... 5 2 2017 7 2.1 2017............................... 7 2.2 2017......................... 8 3 2016 9 3.1 2016...............................
More informationn 2 + π2 6 x [10 n x] x = lim n 10 n n 10 k x 1.1. a 1, a 2,, a n, (a n ) n=1 {a n } n=1 1.2 ( ). {a n } n=1 Q ε > 0 N N m, n N a m
1 1 1 + 1 4 + + 1 n 2 + π2 6 x [10 n x] x = lim n 10 n n 10 k x 1.1. a 1, a 2,, a n, (a n ) n=1 {a n } n=1 1.2 ( ). {a n } n=1 Q ε > 0 N N m, n N a m a n < ε 1 1. ε = 10 1 N m, n N a m a n < ε = 10 1 N
More information0 1
9 - -R -V -K - -V - -V 3 0 3 3 3 001 0 001 00 0 00 1 0 11 1 0 11 10 00 0 10 00 0 0 1 3 F X1CE G XCE CV Cm H X111CE C1V Cm C1.W J X1CE CV CV Cm E X1CE C1V Cm K X11CE C1V m V L X11BCE CV m 1.W C90V M XCE
More informationメディカルカタログ2018_japan
Originality S atisfaction Autonomy Knowledge I mprovement and Innovation Trademark 01 PPE http://www.osakimedical.co.jp/ 179 ISO 9001ISO13485 ISO9001 ISO13485 OB 02 P104 OS OS P09/10 P11 P12 P12 P12 Y
More information1) a) b) CRP c) d) e) a,b b,c c,d d,e a,e b,d 2) CKD a) ACE ARB b) 2mg/dL ACE ARB c) 2mg/dL d) e) ACE ARB a,b b,c c,d d,e a,e b,d 3) a) 130/85mmHg b)
2010.1.13 1) 4) 2 18 1) 1 2 3 4 2) 1 2 85 3 3) 1 metabolizer 2 metabolizer 3 metabolizer 4 metabolizer 4) CYP 1 2 metabolizer 3 metabolizer 4 5 6 4 7 2 5 (PPI) 1 2 PPI 2 3 2 3 3 3 3 PPI 3 1 ph 4 5 1) 5)
More information国試過去問集.PDF
I 89 16 3 130 ab c AMPcAMP a 1 --- b c --- 2 --- --- 3 --- --- 4 --- --- 5 --- --- camp camp Ca 2+ β1 camp A camp camp A β1 p.156 β p.146 b. p.157 p135 (ANP) p157 c PDE-III p.157 p.157, 183 PDE C Ca PDE-III
More information2 A B A B A A B Ea 1 51 Ea 1 A B A B B A B B A Ea 2 A B Ea 1 ( )k 1 Ea 1 Ea 2 Arrhenius 53 Ea R T k 1 = χe 1 Ea RT k 2 = χe 2 Ea RT 53 A B A B
5. A B B A B A B B A A B A B 2 A [A] B [B] 51 v = k[a][b] 51 A B 3 0 273.16 A B A B A B A A [A] 52 v= k[a] 52 A B 55 2 A B A B A A B Ea 1 51 Ea 1 A B A B B A B B A Ea 2 A B Ea 1 ( )k 1 Ea 1 Ea 2 Arrhenius
More information土壌の観察・実験テキスト −土壌を調べよう!−
( ) 2006 7 20 i 21 1962 1969 1987 1992 2005 65 1972 1977 1997 1977 1998 1982 1998 2002 2004 2005 SPP 1999 ii 1 g cm m 6378km ( ) 4.2, 4.3 5.1 7.1 8.1 4.1 7.3, 7.4 7.1 1 2 7.1 8.2 2 5 6 1, 2 2.3 4.2, 4.3
More informationContents 4 06 IP2 41 Thermo Scientific Nalgene Nalgene
Nalgene & Packaging plastic Bottles & Vials Contents 4 06 IP2 41 Thermo Scientific Nalgene 5 07 42 8 08 43 9 09 45 11 10 46 Nalgene 12 11 50 13 12 53 01 20 13 61 02 28 14 64 03 33 15 66 04 37 16 / 67 05
More informationAgilent 7900 ICP-MS 1 1 Ed McCurdy 2 1 Agilent Technologies, Japan 2 Agilent Technologies, UK
Agilent 7900 ICP-MS 1 1 Ed McCurdy 2 1 Agilent Technologies, Japan 2 Agilent Technologies, UK Na P K Ca Co Cu Sr Cd Ce Cs Tl 11 [1]18 [2] (FAO) (WTO) (Codex) Pb Cd As Sn Pb 0.3 mg/kg Cd 0.4 mg/kg 0.2 mg/kg
More informationpositron 1930 Dirac 1933 Anderson m 22Na(hl=2.6years), 58Co(hl=71days), 64Cu(hl=12hour) 68Ge(hl=288days) MeV : thermalization m psec 100
positron 1930 Dirac 1933 Anderson m 22Na(hl=2.6years), 58Co(hl=71days), 64Cu(hl=12hour) 68Ge(hl=288days) 0.5 1.5MeV : thermalization 10 100 m psec 100psec nsec E total = 2mc 2 + E e + + E e Ee+ Ee-c mc
More informationbook.pdf
B O N D DIY PRODUCTS 1 2 3 INDEX 37 2way 1 #04920 26 B1 3kg P #41947 13 500g #40117 14 CH18 1kg #40127 P 3kg #40140 14 CH18 5kg P #40177 14 CH18750 750g #40167 14 CH20 3kg P #40240 14 CH35 3kg P #40640
More information/12/28 UP 3+, TP 4.2g/dl, Alb 1.9g/dl PSL 50mg/day 1/17 PSL 45mg/day PSL 2006/4/4 PSL 30mg/day mpsl mpsl1000mg 3 2 5/ :90 / :114/64 mmhg
17 2005/12/28 UP 3+, TP 4.2g/dl, Alb 1.9g/dl PSL 50mg/day 1/17 PSL 45mg/day PSL 2006/4/4 PSL 30mg/day mpsl mpsl1000mg 32 5/8 36.1 :90 /:114/64 mmhg 166.2 cm64.3 kg 3.9 g/dl 1.6 g/dl 382 mg/dl 408 mg/dl
More information0.5mg (mg 2mg 3mg 50mg 00mg 4mg mg 0.5mg/g 0.5mg/g mg/g 2mg/g mg mg 00mg 5mg 0mg 0mg 0mg 65mg/g 5mg L- 200mg 4mEq/g 2.5mEq 5mEq 50mg 00mg 05mg 25mg 00
042007 6 4 2 2 7 4 283 2 0 7 337 3 4 9 84 3 0 5 355 4 4 5 82 4 7 5 249 5 3 3 5 4 22 75 2 0 6 3 7 3 7 9 4 5 4 76 4 0 6 5 5 2 5 7 22 2 3 0 9 9 790 6 7 2 0.5mg (mg 2mg 3mg 50mg 00mg 4mg mg 0.5mg/g 0.5mg/g
More informationA(6, 13) B(1, 1) 65 y C 2 A(2, 1) B( 3, 2) C 66 x + 2y 1 = 0 2 A(1, 1) B(3, 0) P 67 3 A(3, 3) B(1, 2) C(4, 0) (1) ABC G (2) 3 A B C P 6
1 1 1.1 64 A6, 1) B1, 1) 65 C A, 1) B, ) C 66 + 1 = 0 A1, 1) B, 0) P 67 A, ) B1, ) C4, 0) 1) ABC G ) A B C P 64 A 1, 1) B, ) AB AB = 1) + 1) A 1, 1) 1 B, ) 1 65 66 65 C0, k) 66 1 p, p) 1 1 A B AB A 67
More information2 章 +αの 情 報 に 着 目 する! 1 血 球 算 定 検 査 結 果 2 生 化 学 検 査 結 果 手 がかりに 乏 しいのも+α 1 症 例 をみてみよう! 1 60 吉 見 祐 輔 1 2 11percutaneous coronary intervention PCI104 38.
2 章 +αの 情 報 に 着 目 する! 1 血 球 算 定 検 査 結 果 2 生 化 学 検 査 結 果 手 がかりに 乏 しいのも+α 1 症 例 をみてみよう! 1 60 吉 見 祐 輔 1 2 11percutaneous coronary intervention PCI104 38.1 130 75mmHg 83 16 SpO 297 1 3 WBCL RBC10 4 L Hb g
More information006 11 8 0 3 1 5 1.1..................... 5 1......................... 6 1.3.................... 6 1.4.................. 8 1.5................... 8 1.6................... 10 1.6.1......................
More information2 2 MATHEMATICS.PDF 200-2-0 3 2 (p n ), ( ) 7 3 4 6 5 20 6 GL 2 (Z) SL 2 (Z) 27 7 29 8 SL 2 (Z) 35 9 2 40 0 2 46 48 2 2 5 3 2 2 58 4 2 6 5 2 65 6 2 67 7 2 69 2 , a 0 + a + a 2 +... b b 2 b 3 () + b n a
More informationc 2009 i
I 2009 c 2009 i 0 1 0.0................................... 1 0.1.............................. 3 0.2.............................. 5 1 7 1.1................................. 7 1.2..............................
More informationC033** of 7 C034** PEG-IFN-2b + IFN -2b + 78 HCV-RNA PEG-IFN-2b IFN-2b n=250 n=200 n= =10 % % 85 % 74 % %
2.7.6.9 2.7.6.9.1 Genotype 1 C PEG-IFN-2b+ C033* Genotype 1 C PEG-IFN-2b + IFN-2b + 2.7.6-54 2.7.6-54 C033* 1 of 7 Genotype 1 C PEG-IFN-2b+ Genotype 1 C PEG-IFN-2b + IFN-2b + 24 HCV-RNA 48 24 follow-up
More information希少金属資源 -新たな段階に入った資源問題-
H 耐用 TMR 占有増大 Li 94.5 4CL 0 Na 56 0 K 800 6CA 99 Rb 0. Cs 0.0 Fr Be.5 86US 4 Mg 5500 0.07 8CN 5 Ca 0.09 7 Sr 0.5 48ES Ba 0.5 47 Ra Sc. Y 6.7 7 (Ln) 800-97CN 6 (An) Center for Strategic Material NIMS,Japan
More information数学Ⅱ演習(足助・09夏)
II I 9/4/4 9/4/2 z C z z z z, z 2 z, w C zw z w 3 z, w C z + w z + w 4 t R t C t t t t t z z z 2 z C re z z + z z z, im z 2 2 3 z C e z + z + 2 z2 + 3! z3 + z!, I 4 x R e x cos x + sin x 2 z, w C e z+w
More informationL
-G -VG -G -VG.MPa..MPa.1MPa..MPa 1.5MPa 1.5MPa 1.5MPa 1.5MPa 1 s 5 5 - -V 1.51MPa 1.5MPa s s..mpa.mpa 1.5MPa 1.5MPa - -V 1 s s 5 5 1 JISg/H 1. 1.5. 11 SLLBFFB SLLBFTC CCCCBTC..MPa 1.5MPa SLLBFFB CCCCBTC
More informationID POS F
01D8101011L 2005 3 ID POS 2 2 1 F 1... 1 2 ID POS... 2 3... 4 3.1...4 3.2...4 3.3...5 3.4 F...5 3.5...6 3.6 2...6 4... 8 4.1...8 4.2...8 4.3...8 4.4...9 4.5...10 5... 12 5.1...12 5.2...13 5.3...15 5.4...17
More information8 1. 2. 3. 4. 5. 6. 7. 8. 1... 1 1.1.... 1 1.1.1.... 1 1.1.2.... 6 1.2.... 8 1.2.1.... 8 1.2.2....11 1.2.3.... 12 1.2.4.... 12 1.2.5.... 12 1.2.6.... 13 1.2.7.... 14 1.3.... 15 1.3.1.... 15 1.3.2....
More information1. 1 A : l l : (1) l m (m 3) (2) m (3) n (n 3) (4) A α, β γ α β + γ = 2 m l lm n nα nα = lm. α = lm n. m lm 2β 2β = lm β = lm 2. γ l 2. 3
1. 1 A : l l : (1) l m (m 3) (2) m (3) n (n 3) (4) A 2 1 2 1 2 3 α, β γ α β + γ = 2 m l lm n nα nα = lm. α = lm n. m lm 2β 2β = lm β = lm 2. γ l 2. 3 4 P, Q R n = {(x 1, x 2,, x n ) ; x 1, x 2,, x n R}
More information